ANALYZATOR

ANALYZATOR / NEWS CONTEXT

Isomorphic Labs raises $5B for AI drug development

Alphabet-backed Isomorphic Labs raised $5B in a Series C round led by Greenoaks and Sequoia Capital. The AI drug-development developer is valued at about $50B. Funds will be used to advance the IsoDDE platform and internal oncology and immu

📈 AI · C-round funding for AI drug platform impact · 25

exa · contents-summary · 2026-11-17T14:41:34.707287Z 🌍

Model assessments are opinions, not verified price forecasts or trading instructions. Source publication time and assessment time are separate.

Sign in for the full feed →Back to Trendsetter